Cor Vasa 2010, 52(1-2):43-48 | DOI: 10.33678/cor.2010.009

The importance of ventricular dyssynchrony in predicting the response to cardiac resynchronization therapy

Rudolf Praus1,*, Miloslav Tauchman1, Luděk Haman1, Václav Bláha2, Petr Pařízek1
1 I. interní klinika, Fakultní nemocnice Hradec Králové a Lékařská fakulta v Hradci Králové Univerzity Karlovy v Praze, Hradec Králové
2 Katedra veřejného zdravotnictví, Fakulta vojenského zdravotnictví Univerzity obrany, Hradec Králové, Česká republika

Aim: The aims of this prospective study were to define the numbers of responders and non-responders to cardiac resynchronization therapy (CRT) and differences between these groups, and to assess the development of clinical and echocardiographic effects of CRT in the group of responders over a period of time.
Group of patients and methods: A total of 58 patients with a biventricular system implanted from July 2005 through May 2008 were included into the follow-up. The mean age of patients was 67 ± 9 years; they were classified in NYHA Class IV (one patient), III-IV (18 patients), III (23 patients), and II (three patients), with average QRS duration 193 ± 33 ms, and the diagnosis of dilated cardiomyo-pathy (22 patients), coronary artery disease (33 patients), or the presence of both (three patients). At baseline, and three and 15 months after the implantation, the following parameters were assessed: NYHA class, quality of life (QOL) as measured by the Minnesota Living with Heart Failure (MLHF) questionnaire, 6-minute walk test (6MWT), echocardiography including inter- and intraventricular dyssynchrony, dP/dt, and ventricular outflow tract velocity-time integral (VTILVOT). A responder was defined as a patient who had improved in QOL, NYHA class and/or 6MWT by more than 10%.

Results: Fifteen months after CRT initiation, there were 38 responders (66%) and 19 non-responders (33%). The groups differed only in the extent of ventricular dyssynchrony, with responders showing statistically more significant signs of interventricular dyssynchrony [interventricular mechanical delay (IVMD) 62.1 ± 23.1 ms in responders vs. 46.8 ± 30.3 ms in non-responders; p < 0.05] and intraventricular dyssynchrony [the delay between time to peak systolic velocity in the ejection phase in basal septal and basal lateral segments (Ts-lateral-septal) was 71.2 ± 32.0 ms in responders vs. 48.4 ± 29.2 ms in non-responders; p < 0.05]. Statistically significant changes in all monitored parameters in the group of responders occurred as early as three months after CRT initiation. Additional significant changes between months 3 and 15 of follow-up were seen only in three echocardiographic parameters [left ventricular ejection fraction (LVEF) improved from 27.1 ± 9.8% to 32.8 ± 12.5%, p < 0.001), left ventricular end-diastolic diameter (LVEDD) decreased from 66.1 ± 8.3 mm to 64.0 ± 8.1 mm; p < 0.05, and VTI LVOT increased from 16.7 ± 4.1 cm to 18.8 ± 4.4 cm; p < 0.001]. No other statistically significant changes were observed.

Conclusion: Fifteen months after CRT initiation, there were 38 responders (66%) and 19 non-responders (33%) in our series, i.e. numbers similar to those reported in the relevant literature. These groups differ only in the extent of ventricular dyssynchrony before the implantation of a biventricular system. Statistically significant changes in all monitored parameters were observed in the group of responders as early as three months after CRT initiation.

Keywords: Heart failure; Cardiac resynchronization therapy; Ventricular dyssynchrony

Published: January 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Praus R, Tauchman M, Haman L, Bláha V, Pařízek P. The importance of ventricular dyssynchrony in predicting the response to cardiac resynchronization therapy. Cor Vasa. 2010;52(1-2):43-48. doi: 10.33678/cor.2010.009.
Download citation

References

  1. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without implantable defibrillattor in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150. Go to original source... Go to PubMed...
  2. Cleland JGF, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352: 1539-1549. Go to original source... Go to PubMed...
  3. Cleland JGF, Daubert JC, Erdmann E, et al. Long-term effect of cardiac resynchronization on morbidity and mortality in heart failure (CARE-HF trial extension phase). Eur Heart J 2006;27:1928-1932. Go to original source... Go to PubMed...
  4. Abraham WT, Fisher WG, Smith AL, et al; MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346(24):1845-1853. Go to original source... Go to PubMed...
  5. Bordachar P, Lafitte S, Reuter S, et al. Echocardiographic parameters of ventricular dyssynchrony validation in patients with heart failure using sequential biventricular pacing. J Am Coll Cardiol 2004;44:2157-2165. Go to original source... Go to PubMed...
  6. Linde C, Leclercq Ch, Rex S, et al. Long-term benefit of biventricular pacing in progressive heart failure: Results from the Multisite Stimulation In Cardiomyopathy (MUSTIC) Study. J Am Coll Cardiol 2002;40:111-118. Go to original source... Go to PubMed...
  7. Diaz-Infante E, Mont L, Leal J, et al. Predictors of lack of response to resynchronization therapy. Am J Cardiol 2005;95:1436-1440. Go to original source... Go to PubMed...
  8. Breithardt OA, Sinha AM, Schwammenthal E, et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 2003;41:765-770. Go to original source... Go to PubMed...
  9. Gorcsan J 3rd, Tanabe M, Bleeker GB, et al. Combined longitudinal and radial dyssynchrony predicts ventricular response after cardiac resynchronization therapy. J Am Coll Cardiol 2007;50:1476-1483. Go to original source... Go to PubMed...
  10. Bax JJ, Bleeker GB, Marwick TH, et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 2004;44:1834-1840. Go to original source... Go to PubMed...
  11. Bax JJ, Molhoek SG, Marwick TH, et al. Usefulness of myocardial tissue doppler echocardiography to evaluate left ventricular dyssynchrony before and after biventricular pacing in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2003;91:94-97. Go to original source... Go to PubMed...
  12. Penicka M, Bartunek J, De Brune B, et al. Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue doppler imaging echocardiography. Circulation 2004;109:978-983. Go to original source... Go to PubMed...
  13. Yu CM, Fung JW, Zhang Q, et al. Tissue doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circulation 2004;110:66-73. Go to original source... Go to PubMed...
  14. Chung ES, Leon AR, Tavazzi L, et al. Results of the predictors of response to CRT (PROSPECT) Trial. Circulation 2008;117:2608-2616. Go to original source... Go to PubMed...
  15. Bax JJ, Gorscan J 3rd. Echocardiography and noninvasive imaging in cardiac resynchronization therapy: results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) study in perspective. J Am Coll Cardiol 2009;53:1933-1943. Go to original source... Go to PubMed...
  16. Mollema SA, Bleeker GB, van der Wall EE et al. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure. Am J Cardiol 2007;100:1665-1670. Go to original source... Go to PubMed...
  17. Ghio S, Freemantle N, Scelsi L, et al. Long-term left ventricular reverse remodelling with cardiac resynchronization therapy: results from the CARE-HF trial. Eur J Heart Fail 2009;11:480-488. Go to original source... Go to PubMed...
  18. Stockburger M, Fateh-Moghadam S, Nitardy A, et al. Baseline Doppler parameters are useful predictors of chronic left ventricular reduction in size by cardiac resynchronization therapy. Europace 2008;10:69-74. Go to original source... Go to PubMed...
  19. Bader H, Garrique S, Lafitte S, et al. Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients. J Am Coll Cardiol 2004;43:248-256. Go to original source...
  20. Ghio S, Constantin C, Klersy C, et al. Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration. Eur Heart J 2004;25:571-578. Go to original source... Go to PubMed...
  21. Bleeker GB, Mollema SA, Holman ER, et al. Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy. Circulation 2007;116:1440-1448. Go to original source... Go to PubMed...
  22. Ypenburg C, Schalij MJ, Bleeker GB, et al. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J 2007;28:33-41. Go to original source... Go to PubMed...
  23. Shalaby A, El-Saed A, Voigt A, et al. Elevated serum creatinine at baseline predicts poor outcome in patients receiving cardiac resynchronization therapy. Pacing Clin Electrophysiol 2008;31:575-579. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.